Cold irrigation shows promise for reducing post-root canal pain, but evidence remains limited

After a root canal procedure, pain often lingers. Patients emerge from the chair tender and sore, sometimes for days. Dentists have long searched for ways to ease that postoperative discomfort, and a new systematic review of eleven randomized controlled trials suggests that something simple might help: cooling the irrigation fluid used during treatment.

Researchers conducting this meta-analysis, published in Nature, examined whether intracanal cryotherapy—applying chilled saline at temperatures between 2 and 4 degrees Celsius as a final rinse before sealing the tooth—could reduce pain after nonsurgical root canal treatment in patients with symptomatic apical periodontitis, a condition marked by inflammation at the root tip. The evidence they found was encouraging but comes with important caveats. At six, twenty-four, forty-eight, and seventy-two hours after treatment, patients who received cold irrigation reported significantly less pain than those treated with standard room-temperature saline. The effect did not reach statistical significance at the twelve-hour mark, a gap the researchers note may reflect the small number of studies measuring pain at that interval rather than a true absence of benefit.

The mechanism is biologically sound. Cold reduces blood flow to tissues, limiting the spread of inflammatory molecules. It slows metabolic activity and decreases oxygen demand. It also dampens nerve signaling—the very pathways that transmit pain sensation. Experimental work suggests cooling may suppress activation of pain receptors and reduce the release of neuropeptides that amplify discomfort. What makes this finding potentially valuable is its simplicity. The intervention requires no new equipment, adds minimal time to a procedure, and costs little. Most trials used five milliliters to twenty milliliters of saline chilled to between 2 and 4 degrees Celsius, applied for approximately five minutes.

Yet the certainty of this evidence remains low. Of the eleven trials included, only one was judged to have a low risk of bias. Nine others had what researchers call "some concerns"—inconsistencies in how they reported their methods, how they concealed which patients received which treatment, or how they selected which results to publish. Blinding participants and operators to the temperature of the irrigant is nearly impossible; patients and dentists can feel the difference. Pain itself is subjective, influenced by anxiety, expectations, and individual thresholds. Different trials used different pain scales, requiring researchers to convert results into standardized units to compare them. Protocols varied: some used saline at 2 to 4 degrees Celsius, others at 13 to 15 degrees. Some added medications to the irrigant. These variations introduced statistical noise that persisted even after sensitivity analyses.

The benefits appeared consistent across subgroups. Whether a tooth had one root or multiple roots, whether the pulp was irreversibly inflamed or already dead, whether treatment was completed in one visit or multiple visits—cryotherapy reduced pain more than standard care. No serious adverse events were reported. Yet the researchers emphasize that these findings do not establish an optimal temperature, volume, or duration. No specific protocol can yet be recommended as standard practice. The magnitude of clinical benefit also remains unclear. Statistical significance does not always translate to meaningful relief in a patient's lived experience.

The authors call for future trials to adopt standardized protocols, stratify participants by baseline pain severity and pulpal diagnosis, and measure not just pain but also inflammatory biomarkers and patient satisfaction. They note that publication bias could not be fully excluded and that the follow-up periods in existing trials were relatively short. Until higher-quality evidence accumulates, cryotherapy should not replace established pain-control strategies like nonsteroidal anti-inflammatory drugs. But for patients at high risk of severe postoperative pain—those with symptomatic apical periodontitis—it may be worth considering as an adjunct, a simple addition to existing care that costs little and appears to help.